MicroAd,Inc. Logo

MicroAd,Inc.

Data-driven marketing tech providing DSP and SSP solutions for digital advertising.

9553 | T

Overview

Corporate Details

ISIN(s):
JP3860350002
LEI:
Country:
Japan
Address:
渋谷区桜丘町20−1 渋谷インフォスタワー13階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

MicroAd, Inc. is a marketing technology company that utilizes data and predictive analytics to enhance digital advertising. The firm's operations are centered on its proprietary data platform, "UNIVERSE," which aggregates and analyzes extensive online and offline consumer behavior data. MicroAd provides a comprehensive suite of solutions for the advertising ecosystem, including "UNIVERSE Ads," a Demand-Side Platform (DSP) for advertisers to optimize ad delivery, and "MicroAd COMPASS," a Supply-Side Platform (SSP) for media publishers to maximize revenue. By connecting advertisers and media through its advanced technology, the company aims to maximize value for all stakeholders and facilitate effective communication with end-users.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-01 04:30
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.8 KB
2025-06-02 08:35
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.6 KB
2025-05-15 08:39
Report Publication Announcement
確認書
Japanese 8.0 KB
2025-05-15 08:38
Interim Report
半期報告書-第19期(2024/10/01-2025/09/30)
Japanese 191.4 KB
2025-05-01 02:00
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.6 KB
2025-04-01 02:05
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.6 KB
2025-03-03 07:30
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.4 KB
2025-02-06 03:30
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.9 KB
2025-01-14 05:35
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.5 KB
2024-12-23 05:09
Post-Annual General Meeting Information
臨時報告書
Japanese 23.6 KB
2024-12-23 05:08
Governance Information
内部統制報告書-第18期(2023/10/01-2024/09/30)
Japanese 22.2 KB
2024-12-20 06:46
Registration Form
確認書
Japanese 8.0 KB
2024-12-20 06:45
Annual / Quarterly Financial Statement
有価証券報告書-第18期(2023/10/01-2024/09/30)
Japanese 2.8 MB
2024-09-30 05:25
M&A Activity
臨時報告書
Japanese 19.4 KB
2024-05-15 08:01
Report Publication Announcement
確認書
Japanese 8.0 KB

Automate Your Workflow. Get a real-time feed of all MicroAd,Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for MicroAd,Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for MicroAd,Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan 4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan 302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden BTS
B.U Technology Logo
Commercializes university research via IP management, licensing, and new venture creation.
South Korea 230980
Advancing high-grade copper and precious metal projects from discovery to production.
Canada N/A
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.